Cotton-Oneill Diabetes and End is a clinical research site located in Topeka, Kansas, United States 66606-2806.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Cotton-Oneill Diabetes and End has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: Overweight, Obesity, Type 2 Diabetes Mellitus.
Sponsors: Novo Nordisk A/S.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cotton-Oneill Diabetes and End has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cotton-Oneill Diabetes and End has 4 clinical trials on record, with 1 currently active. Their work covers Overweight, Obesity, Type 2 Diabetes Mellitus.
Cotton-Oneill Diabetes and End has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.